Jun 7, 2023 04:00PM
Mar 21, 2023 04:04PM
Mar 21, 2023 04:01PM
Mar 15, 2023 07:30AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Nov 4, 2022 07:30AM Navidea Biopharmaceuticals to Host Third Quarter 2022 Earnings Conference Call and Business Update
Aug 30, 2022 09:30AM
Aug 15, 2022 08:30AM
Aug 4, 2022 07:30AM
May 12, 2022 07:30AM
May 5, 2022 07:30AM
Mar 23, 2022 04:04PM
Mar 23, 2022 07:32AM Navidea Biopharma (NAVB) Reports Q4 Results
Mar 23, 2022 07:30AM
Mar 23, 2022 07:30AM
Mar 16, 2022 07:30AM
Dec 15, 2021 05:46PM
Nov 10, 2021 04:05PM
Nov 10, 2021 04:01PM
Nov 3, 2021 04:01PM Navidea Biopharmaceuticals to Host Third Quarter 2021 Earnings Conference Call and Business Update
Aug 11, 2021 04:26PM
Aug 11, 2021 04:01PM
Aug 4, 2021 07:30AM
May 11, 2021 04:42PM
May 11, 2021 04:01PM
May 4, 2021 07:30AM
Mar 24, 2021 04:23PM Navidea Biopharma (NAVB) Tops Q4 EPS by 1c, Revenues Miss
Mar 24, 2021 04:21PM
Mar 17, 2021 07:30AM
Mar 2, 2021 07:33AM
Mar 2, 2021 07:30AM
Nov 12, 2020 04:04PM
Nov 12, 2020 04:02PM
Nov 5, 2020 04:01PM Navidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate Update
Aug 13, 2020 04:32PM
Aug 13, 2020 04:09PM
Aug 6, 2020 04:15PM
May 14, 2020 04:25PM
May 14, 2020 04:01PM
May 11, 2020 07:41AM
May 11, 2020 07:30AM Navidea Biopharmaceuticals Regains Commercialization and Distributions Rights in Europe for LYMPHOSEEK®
May 7, 2020 07:00AM
Mar 11, 2020 04:14PM
Mar 11, 2020 04:05PM
Mar 4, 2020 08:00AM
Nov 7, 2019 04:05PM
Oct 31, 2019 07:30AM
Aug 8, 2019 05:35PM Navidea Biopharma (NAVB) Reports Q2 Loss of $0.24
Aug 8, 2019 04:05PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All